Development of a Virtual Reality Spatial Retraining Therapy to Improve Neglect in Stroke Survivors (VR-SRT)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04793516 |
|
Recruitment Status :
Recruiting
First Posted : March 11, 2021
Last Update Posted : March 11, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Stroke Spatial Neglect | Other: VR Therapy Game | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 10 participants |
| Allocation: | N/A |
| Intervention Model: | Single Group Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | Development of a Virtual Reality Spatial Retraining Therapy to Improve Neglect in Stroke Survivors |
| Actual Study Start Date : | March 25, 2019 |
| Estimated Primary Completion Date : | December 31, 2021 |
| Estimated Study Completion Date : | December 31, 2021 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: VR-based spatial retraining
Game-like therapy activities will be taken place in a virtual environment, provided through an immersive head-mounted display.
|
Other: VR Therapy Game
Participants will complete 5 sessions of VR-based therapy modules developed for use in helping people with spatial neglect. These 5 sessions will be completed over 7-8 days. |
- Behavioral Inattention Test [ Time Frame: At baseline, after intervention, and two weeks after intervention ]A battery of visuospatial tests using paper and pencil to perform line crossing, star cancellation, letter cancellation, line bisection, figure copying, and drawing. The test is scored from 0 to 146, with higher values indicating better performance.
- Simulator Sickness Questionnaire [ Time Frame: After intervention ]A 16-item questionnaire asking for adverse feelings related to the virtual reality experience. Example items are eye strain, difficulty concentrating, headache, and burping. Each item is rated none, slight. moderate, or severe.
- Semi-structured interview [ Time Frame: Two weeks after intervention ]A 10-minute phone interview will be conducted to explore the subjective experience of the intervention.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Read and speak English fluently
- Have a history of one stroke event that injured one cerebral hemisphere
- Presence of moderate to severe spatial neglect
Exclusion Criteria:
- History of progressive neurological disorders
- History of significant psychiatric disorders
- History of vestibular disorders
- Living outside a 50-mile radius of Kessler Foundation (located in West Orange, NJ)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04793516
| Contact: Jenny Masmela | 973-324-3564 | jmasmela@kesslerfoundation.org |
| United States, New Jersey | |
| Kessler Foundation | Recruiting |
| West Orange, New Jersey, United States, 07052 | |
| Contact: Jenny Masmela 973-324-3564 jmasmela@kesslerfoundation.org | |
| Principal Investigator: | Peii Chen, PhD | Kessler Foundation |
| Responsible Party: | Peii Chen, Senior Research Scientist, PI, Kessler Foundation |
| ClinicalTrials.gov Identifier: | NCT04793516 |
| Other Study ID Numbers: |
E-996-17 |
| First Posted: | March 11, 2021 Key Record Dates |
| Last Update Posted: | March 11, 2021 |
| Last Verified: | March 2021 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Stroke Cerebrovascular Disorders Brain Diseases Central Nervous System Diseases |
Nervous System Diseases Vascular Diseases Cardiovascular Diseases |

